Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke

Clinical Neurology and Neurosurgery

Volumn 125, Issue , 2014, Pages 189-193

  Van Hooff, Robbert Jan ^a   Nieboer, Koenraad ^a   De Smedt, Ann ^a   Moens, Maarten ^a   De Deyn, Peter Paul ^b,c   De Keyser, Jacques ^a,c   Brouns, Raf ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Prognosis; Stroke, acute; Stroke, outcome; Thrombolysis

Indexed keywords

ALTEPLASE; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; RANKIN SCALE; RISK ASSESSMENT; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BRAIN HEMORRHAGE; CALIBRATION; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DENSE CEREBRAL ARTERY PRESTROKE MODIFIED RANKIN SCALE AGE GLUCOSE ONSET TO TREATMENT TIME NIHSS SCORE; FUNCTIONAL STATUS; GLUCOSE RACE AGE SEX PRESSURE STROKE SEVERITY; HEMORRHAGE AFTER THROMBOLYSIS SCORE; ISCORE; MULTICENTER STROKE SURVEY SCORE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; RELIABILITY; SAFE IMPLEMENTATION OF TREATMENTS IN STROKE SYMPTOMATIC INTRACEREBRAL HEMORRHAGE SCORE; SCORING SYSTEM; STROKE THROMBOLYTIC PREDICTIVE INSTRUMENT; SUGAR EARLY INFARCT DENSE CEREBRAL ARTERY AGE NIHSS SCORE; VALIDATION STUDY;

EID: 84906836947     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2014.08.011     Document Type: Article

References (24)

1. K.R. Lees, E. Bluhmki, R. von Kummer, T.G. Brott, D. Toni, and J.C. Grotta et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials Lancet 375 9727 2010 1695 1703 10.1016/S0140-6736(10)60491-6 pii:S0140-6736(10)60491-6
2. G. Saposnik, B. Young, B. Silver, S. Di Legge, F. Webster, and V. Beletsky et al. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome JAMA 292 15 2004 1839 1844 doi:292/15/1839 [pii].10.1001/jama.292.15.1839 (Pubitemid 40169294)
3. J.L. Saver Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm Stroke 38 8 2007 2279 2283 doi:STROKEAHA.107.487009 [pii].10.1161/STROKEAHA.107.487009 (Pubitemid 47457569)
4. E.C. Jauch, J.L. Saver, H.P. Adams Jr., A. Bruno, J.J. Connors, and B.M. Demaerschalk et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 3 2013 870 947 10.1161/STR.0b013e318284056a
5. D.M. Kent, H.P. Selker, R. Ruthazer, E. Bluhmki, and W. Hacke The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke Stroke 37 12 2006 2957 2962 doi:01.STR.0000249054.96644.c6 [pii].10.1161/01.STR.0000249054.96644.c6 (Pubitemid 44900816)
6. M. Uyttenboogaart, R.E. Stewart, P.C. Vroomen, G.J. Luijckx, and J. De Keyser Utility of the stroke-thrombolytic predictive instrument J Neurol Neurosurg Psychiatry 79 9 2008 1079 1081 doi:jnnp.2008.145698 [pii].10.1136/jnnp.2008.145698
7. B. Cucchiara, D. Tanne, S.R. Levine, A.M. Demchuk, and S. Kasner A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke J Stroke Cerebrovasc Dis 17 6 2008 331 333 10.1016/j.jstrokecerebrovasdis.2008.03.012 pii:S1052-3057(08)00084-0
8. B. Cucchiara, S. Kasner, D. Tanne, S. Levine, A. Demchuk, and S. Messe et al. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage Int J Stroke 6 2 2011 109 111 10.1111/j.1747-4949. 2010.00556.x
9. M. Lou, A. Safdar, M. Mehdiratta, S. Kumar, G. Schlaug, and L. Caplan et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis Neurology 71 18 2008 1417 1423 doi:71/18/1417 [pii].10.1212/01.wnl. 0000330297.58334.dd
10. M. Mazya, J.A. Egido, G.A. Ford, K.R. Lees, R. Mikulik, and D. Toni et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score Stroke 43 6 2012 1524 1531 doi:STROKEAHA.111.644815 [pii].10.1161/STROKEAHA.111.644815
11. G. Saposnik, J. Fang, M.K. Kapral, J.V. Tu, M. Mamdani, and P. Austin et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke Stroke 43 5 2012 1315 1322 doi:STROKEAHA.111.646265 [pii].10.1161/ STROKEAHA.111.646265
12. D. Strbian, S. Engelter, P. Michel, A. Meretoja, L. Sekoranja, and F.J. Ahlhelm et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score Ann Neurol 71 5 2012 634 641 10.1002/ana.23546
13. D. Strbian, A. Meretoja, F.J. Ahlhelm, J. Pitkaniemi, P. Lyrer, and M. Kaste et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score Neurology 78 6 2012 427 432 doi:78/6/427 [pii].10.1212/WNL.0b013e318245d2a9
14. B.K. Menon, J.L. Saver, S. Prabhakaran, M. Reeves, L. Liang, and D.M. Olson et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator Stroke 43 9 2012 2293 2299 doi:STROKEAHA.112.660415 [pii].10.1161/STROKEAHA.112. 660415
15. A. Meretoja, J. Putaala, T. Tatlisumak, S. Atula, V. Artto, and S. Curtze et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke Stroke 41 7 2010 1450 1458 doi:STROKEAHA.109.576140 [pii].10.1161/STROKEAHA.109.576140
16. J.A. Ellis, B.E. Youngerman, R.T. Higashida, D. Altschul, and P.M. Meyers Endovascular treatment strategies for acute ischemic stroke Int J Stroke 6 6 2011 511 522 10.1111/j.1747-4949.2011.00670.x
17. E.M. Agency Actilyse 2002 European Medicines Agency http://www.ema. europa.eu/docs/en-GB/document-library/Referrals-document/Actilyse-29/ WC500010327.pdf [accessed 06.09.12]
18. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 24 1995 1581 1587 10.1056/NEJM199512143332401
19. W. Hacke, M. Kaste, C. Fieschi, R. von Kummer, A. Davalos, and D. Meier et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators Lancet 352 9136 1998 1245 1251 (Pubitemid 28470336)
20. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1 1982 29 36 (Pubitemid 12142173)
21. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 3 1988 837 845
22. K.C. Johnston, A.F. Connors Jr., D.P. Wagner, and E.C. Haley Jr. Predicting outcome in ischemic stroke: external validation of predictive risk models Stroke 34 1 2003 200 202 (Pubitemid 36070822)
23. J. Kwan, P. Hand, and P. Sandercock A systematic review of barriers to delivery of thrombolysis for acute stroke Age Ageing 33 2 2004 116 121 10.1093/ageing/afh064.33/2/116 (Pubitemid 38313108)
24. J.M. Wardlaw, V. Murray, E. Berge, G. del Zoppo, P. Sandercock, and R.L. Lindley et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis Lancet 379 9834 2012 2364 2372 10.1016/S0140-6736(12)60738-7